Clinical Trial: 21304

Trial Status: Open
Disease Type: Solid Tumors All
Trial ID 21304
Sponsor ID Toray Industries

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

Principal Investigator
Christina Brzezniak, DO
5 Locations

Locations

Alexandria Office

Arlington Office

Fairfax Office

Gainesville Office

Loudoun Office

Learn More About This Trial

Other Relevant Trials
Trial ID TSC-007
Sponsor ID PRECISION-1

A Phase 2 multi-center open-label basket trial of ABI-009 (nab-sirolimus) for adult and adolescent patients with solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes

Trial ID 516-014
Sponsor ID Mirati

A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies